112 related articles for article (PubMed ID: 31156017)
21. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
22. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
Rahardjo D; Kamil ST; Pakasi LS
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
[TBL] [Abstract][Full Text] [Related]
23. Higher sex hormone-binding globulin and lower bioavailable testosterone are related to prostate cancer detection on prostate biopsy.
García-Cruz E; Carrión Puig A; García-Larrosa A; Sallent A; Castañeda-Argáiz R; Piqueras M; Ribal MJ; Leibar-Tamayo A; Romero-Otero J; Alcaraz A
Scand J Urol; 2013 Aug; 47(4):282-9. PubMed ID: 23181478
[TBL] [Abstract][Full Text] [Related]
24. Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy.
García-Cruz E; Huguet J; Piqueras M; Márquez MP; Peri L; Izquierdo L; Franco A; Alvarez-Vijande R; Ribal MJ; Alcaraz A
World J Urol; 2012 Jun; 30(3):361-5. PubMed ID: 21833558
[TBL] [Abstract][Full Text] [Related]
25. Prevelance of prostate cancer among Turkish men with prostate-specific antigen level of ≤100 ng/ml.
Çalışkan S
J Cancer Res Ther; 2018; 14(6):1256-1259. PubMed ID: 30488840
[TBL] [Abstract][Full Text] [Related]
26. Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination.
Miotto A; Srougi M; Brito GA; Leite KM; Nesrallah AJ; Ortiz V
Int Braz J Urol; 2004; 30(2):109-13. PubMed ID: 15703091
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features of prostate cancer detected by transrectal ultrasonography-guided systematic six-sextant biopsy.
Ito K; Ichinose Y; Kubota Y; Imai K; Yamanaka H
Int J Urol; 1997 Sep; 4(5):474-9. PubMed ID: 9354949
[TBL] [Abstract][Full Text] [Related]
28. Does transrectal ultrasound guided eight-core prostate biopsy improve cancer detection rates in patients with prostate-specific antigen levels of 4.1-10 ng/mL?
Yamamoto S; Ito T; Aizawa T; Noda K; Umezu K; Ohtsuru N; Hata K
Int J Urol; 2004 Jun; 11(6):386-91. PubMed ID: 15157207
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and clinical significance of prostate cancer among 12,682 men with normal digital rectal examination, low PSA levels (< or =4 ng/ml) and percent free PSA cutoff values of 15 and 20%.
Pepe P; Panella P; Savoca F; Cacciola A; D'Arrigo L; Dibenedetto G; Pennisi M; Aragona F
Urol Int; 2007; 78(4):308-12. PubMed ID: 17495487
[TBL] [Abstract][Full Text] [Related]
30. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer screening in Tyrol, Austria: experience and results.
Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
[TBL] [Abstract][Full Text] [Related]
32. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.
Lee DH; Nam JK; Park SW; Lee SS; Han JY; Lee SD; Lee JW; Chung MK
Yonsei Med J; 2016 May; 57(3):565-71. PubMed ID: 26996553
[TBL] [Abstract][Full Text] [Related]
33. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.
Catalona WJ; Richie JP; deKernion JB; Ahmann FR; Ratliff TL; Dalkin BL; Kavoussi LR; MacFarlane MT; Southwick PC
J Urol; 1994 Dec; 152(6 Pt 1):2031-6. PubMed ID: 7525994
[TBL] [Abstract][Full Text] [Related]
34. Are prostatic biopsies necessary in men aged > or =80 years?
Bott SR; Foley CL; Bull MD; Reddy CC; Freeman A; Montgomery BS; Langley SE
BJU Int; 2007 Feb; 99(2):335-8. PubMed ID: 17326264
[TBL] [Abstract][Full Text] [Related]
35. Indications for extended 14-core transrectal ultrasound-guided prostate biopsy.
Uno H; Nakano M; Ehara H; Deguchi T
Urology; 2008 Jan; 71(1):23-7. PubMed ID: 18242358
[TBL] [Abstract][Full Text] [Related]
36. Predicting the extent of prostate cancer using the combination of systematic biopsy and serum prostate-specific antigen in Japanese men.
Gohji K; Okamoto M; Takenaka A; Nomi M; Fujii A
BJU Int; 1999 Jan; 83(1):39-42. PubMed ID: 10233449
[TBL] [Abstract][Full Text] [Related]
37. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
38. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.
Luboldt HJ; Bex A; Swoboda A; Hüsing J; Rübben H;
Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671
[TBL] [Abstract][Full Text] [Related]
39. Is prostate volume better than PSA density and free/total PSA ratio in predicting prostate cancer in patients with PSA 2.5-10 ng/mL and 10.1-30 ng/mL?
Erdogan A; Polat S; Keskin E; Turan A
Aging Male; 2020 Mar; 23(1):59-65. PubMed ID: 30862227
[No Abstract] [Full Text] [Related]
40. Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL.
Babaian RJ; Fritsche H; Ayala A; Bhadkamkar V; Johnston DA; Naccarato W; Zhang Z
Urology; 2000 Dec; 56(6):1000-6. PubMed ID: 11113747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
